A foundation model for bioactivity prediction using pairwise meta-learning
Bin Feng,Zequn Liu,Nanlan Huang,Zhiping Xiao,Haomiao Zhang,Srbuhi Mirzoyan,Hanwen Xu,Jiaran Hao,Yinghui Xu,Ming Zhang,Sheng Wang,Feng,B.,Liu,Z.,Huang,N.,Xiao,Z.,Zhang,H.,Mirzoyan,S.,Xu,H.,Hao,J.,Xu,Y.,Zhang,M.,Wang,S.
DOI: https://doi.org/10.1101/2023.10.30.564861
2023-11-03
bioRxiv
Abstract:Compound bioactivity plays an important role in different stages of drug development and discovery. Existing machine learning approaches have poor generalization ability in compound bioactivity prediction due to the small number of compounds in each assay and incompatible measurements among assays. Here, we propose ActFound, a foundation model for bioactivity prediction trained on 2.3 million experimentally-measured bioactivity compounds and 50,869 assays from ChEMBL and BindingDB. The key idea of ActFound is to employ pairwise learning to learn the relative value differences between two compounds within the same assay to circumvent the incompatibility among assays. ActFound further exploits meta-learning to jointly optimize the model from all assays. On six real-world bioactivity datasets, ActFound demonstrates accurate in-domain prediction and strong generalization across datasets, assay types, and molecular scaffolds. We also demonstrated that ActFound can be used as an accurate alternative to the leading computational chemistry software FEP+(OPLS4) by achieving comparable performance when only using a few data points for fine-tuning. The promising results of ActFound indicate that ActFound can be an effective foundation model for a wide range of tasks in compound bioactivity prediction, paving the path for machine learning-based drug development and discovery.